The Digital RESI Europe Experience

10 Mar

By Gregory Mannix, Chief Conference Officer, Vice President International Business Development, LSN

The program guide and the “live” agenda will navigate you to the right RESI event and meeting.

A typical RESI conference attendee in the physical world receives the program guide and uses the agenda to plan out their day. So, the first hurdle for the digital event is how to navigate through a virtual conference? LSN is taking the “agenda page” of the Digital RESI Europe program guide and making it an interactive navigation vehicle for the three-day virtual event. All attendees will have 24/7 access to the RESI investor and workshop panels, Innovation Challenge finalist presentations, Featured Company Pitches, Exhibitor portal and, most importantly, an enhanced and expanded Partnering Platform.

The Digital RESI Europe Agenda. https://www.resiconference.com/resiagenda/

LSN is going to embed links throughout the agenda that will allow RESI Europe attendees to easily navigate through all the aspects of the virtual conference. This means more opportunity to get at the amazing content presented by the who’s who of early stage global partnering. Click on the panel or workshop you wish to attend, and you will be connected to a prerecorded panel video. Click on the Partnering Platform of the agenda and be linked to a new enhanced partnering software powered by Meeting Mojo for your live video conference with screen sharing functionality. As compared to the standard 1-day physical conference, Digital RESI Europe Partnering has now been expanded to 12 hours per day over 3 days for you to maximize your number of meetings. Click on the company presentation you want to see/hear, and the prerecorded video will surface for your viewing pleasure. Click on the Exhibition Portal and see the 30 top ranked Innovation Challenge companies and meet all of our featured exhibitors and tech hubs.

LSN is fortunate in that for Digital RESI Europe to succeed, LSN must stick to our core value, which is matching early stage companies with early stage partners and facilitating 1:1 partnering meetings. If we get that bit right, we will have preserved our value. LSN is confident that the virtual meeting scenario will be a success and may be a new way to connect buyers and sellers!

1:1 Partnering Meetings

Digital RESI Europe is a dedicated global partnering event. RESI has the most powerful partnering platform because we can match companies and partners based on stage of development and product fit. The core value is our 1:1 partnering, that RESI has used since 2013. The partnering software is owned and operated by our partner Meeting Mojo, which is implementing a video meeting component embedded in the application. Any RESI attendee can use this video capability to “attend” their scheduled meeting. The challenge for all the attendees will be the geographic time zone issues and that may require some flexibility. Fortunately, being virtual and being able to extend the conference from a one day physical to a three-day virtual conference means more availability to find mutual time slots that will work for both parties.

Investor and Workshop Panels

RESI is unique in that we dedicate most of our panels to the ten categories of investors and partners who play in the early-stage space, cross-border and across the silos of drugs, devices, diagnostics and digital health. What attendees learn from these panels is who the right players are, the best way to reach out, how they source technology (including RESI), how they vet companies and how they help early stage companies with whom they have relationships develop. The information that entrepreneurs receive from these panels is invaluable in helping them understand the nuances of how all the different players in the space approach early stage startups.

 

Featured Company Pitch Session Presenting Companies

Early stage life science companies that are actively raising seed capital ($25k to 2 MM), Series A ($2 MM to 10 MM) or Series B ($10 MM to 50 MM) use RESI to get in front of a panel of qualified investors in their market segment and pitch their company and product. The investors ask questions, provide feedback and commentary on the pitch, company and product. These presentations are invaluable in the journey to raising capital. Digital RESI Europe will feature presenting companies prominently on the conference website, and program guide and will post a prerecorded version of their pitch. Investors and industry experts will be encouraged to submit written questions to the pitching companies.

LSN Created a Virtual Exhibitor Hall

The Exhibition Portal will feature all our Digital RESI Europe exhibitors and our Innovation Challenge finalists.

Innovation Challenge

RESI is world renowned for its Innovation Challenge where, at every RESI conference, we feature select companies that have been scored and ranked with the LSN expert system for “investability.” We take the top 30 firms who apply and feature them with an easel in the exhibition hall. LSN has created a virtual exhibition hall where partners can see their poster board and also hear them give a prerecorded 3-5-minute pitch on their technology. The Innovation Challenge participants are virtually voted on with “RESI cash” and the winners will be awarded prizes and get featured in the LSN weekly newsletter.

Virtual Exhibitor Hall

The RESI exhibitors and sponsors will be featured on a dedicated page with a virtual exhibitor booth, showcasing their services and the value they can provide. Participating tech hubs can highlight their programs and constituent companies.

DIGITAL RESI EUROPE – FAQ

10 Mar

By Karen Deyo, Senior Investor Research Analyst, LSN

How exactly will Digital RESI Europe work?

LSN is going to embed links throughout The RESI Europe Agenda that will allow Digital RESI Europe attendees to easily navigate through all the aspects of the virtual conference. This means more opportunity to get at the amazing content presented by the who’s who of early stage global partnering. At their discretion attendees can now immerse themselves in ALL the content being delivered, and have more time to engage with participating companies and investors.

Will the panels and workshops be available over the three days?

Yes, attendees will have full virtual access to navigating all components of the conference over these three days. Not only will you be able to see “day of” content but also past panels where you can hear firsthand, how these investors and strategic partners source, vet and develop relationships with early stage technology firms.

How will Investor and Workshop panels be presented?

LSN is taking the “agenda page” of the RESI Europe program guide and making it an interactive navigation vehicle for the three-day virtual event. All attendees will have 24/7 digital access to the full day of panels scheduled in the agenda. At the click of a button attendees will be able to review pre-recorded panel discussions at their convenience. LSN will also provide access to past RESI panels of investors and strategic partners explaining their investment mandates for the 4Ds, drugs, devices, diagnostics, and digital health. In addition to providing access to the scheduled panels as well as content from previous RESI conferences, attendees have the additional flexibility of working around scheduled meetings without struggling to balance their schedule.

Is RESI still doing 1:1 partnering?

Yes. Because Digital RESI Europe is now virtual, LSN can extend RESI 1:1 Partnering from one physical day to three virtual days. This will give you more opportunity to arrange more partnering meetings. The RESI Partnering Platform will allow for video conferencing and screen sharing to make your meetings more effective.

Will RESI partnering cover the three virtual days?

Yes. Digital RESI Europe attendees will be able to take advantage of more than three times as many partner meeting slots, have more opportunity to see relevant partner content and the ability to pick and choose meetings, panels and workshops from the comfort of your home or office.

I go to RESI to meet investors and strategic partners – how will that be affected?

RESI is unique in that it is a dedicated partnering conference. At any given RESI conference, LSN will have between 300 and 600 entrepreneurs and, amazingly, the same number of investors, making for a 1:1 ratio of buyers and sellers. The core value is the capability to utilize the RESI Partnering Platform (powered by Meeting Mojo) for an early stage life science company to meet investors and partners that are a fit for their stage of development and their product set. This makes for compelling, dynamic meetings based on fit.

RESI has been working with Meeting Mojo for RESI as a proprietary partnering software since LSN started the RESI Conference series back in 2013. Originally, LSN jointly designed and developed a capability to match the scientist-entrepreneurs and fundraising CEOs with investors and strategic partners based on data parameters in each parties’ profile. The partnering system includes detailed company profiles, preventing meetings where attendees spend the time discovering they are not a fit for each other, wasting a valuable time slot. RESI partnering stands out in the industry because mismatching is dramatically reduced, ensuring maximum value of your partnering schedule. The three day Digital RESI Europe format will allow attendees to take even more advantage of this unique LSN resource.

Please explain how the Meeting Mojo video software partnering module will work?

We are all familiar with video conferencing and video meetings via our PC applications and mobile cell devices, so this is not a big leap to integrate the video capability into the Meeting Mojo partnering and scheduling software. Most RESI attendees are already familiar with the Meeting Mojo/RESI partnering. You log in as you have in the past and schedule your meetings as before, and at the designated time of your meeting you simply go to the Meeting Mojo partnering site and with a few mouse clicks will be “live” for your partnering meeting.

The virtual meeting platform is seamlessly integrated into the partnering software, and LSN and Meeting Mojo will make step-by-step instructions available. It is easy to use, intuitive and very good quality. We can use Meeting Mojo partnering software to provide a functional equivalent of the physical 1:1 meeting that make RESI a very important global event.

RESI Europe 2020 Innovation Challenge – Check Out the Finalists!

5 Mar

By Claire Jeong, Director of Research, Asia BD, LSN

claire

With less than 3 weeks left until our second RESI Europe conference, we are very excited to announce the RESI Europe Innovation Challenge finalists. The RESI team received applications from all across the globe, boasting an even stronger diversity than our inaugural RESI Europe in Vienna last year.

All registered RESI attendees will receive 5 “RESI Cash”, which they can use to “invest” in the most promising Innovation Challenge companies. As always, we highly encourage all attendees to reserve some time during the conference to browse around the exhibit hall and engage with the finalists who will be eager to pitch their company and the innovative work they are doing to address unmet medical needs.

Thank you for everyone who applied for the Innovation Challenge. For those of you who were not selected, please look out for future opportunities including RESI San Diego (June) and RESI Boston (September).

Congratulations again to the selected RESI Europe Innovation Challenge companies – please see them below!

Therapeutics

 

Medical Device

Digital Health

Diagnostics

 

LSN Making Advances to Grow Its European Ecosystem

5 Mar

By Gregory Mannix, Vice President International Business Development, LSN

I have been spending a great deal of time in Europe developing the LSN European Ecosystem, and this culminated in bringing the RESI Conference Series to Europe for the first time in 2019. The second RESI Europe conference will take place in a few short weeks in Paris on March 23rd. Here is a snapshot of what I have learned from my travels over the last 18 months.

What I see is many early-stage life science companies with great technology, moving and developing within a mostly regional ecosystem. This includes investors, government agencies, angels, family offices, VCs, PEs and Pharma and Medtech players.  The inevitable result is a huge bottleneck in which startups can’t find nearly enough regional investment partners, forcing scientist-entrepreneurs who are looking to raise their series A and B rounds to look outside of the region.  The challenge is that most are not prepared for this change and struggle with cultural and business practice differences. This is where LSN comes in, with valuable insight through our Fundraising Bootcamps and by bringing the global-focused RESI Conference Series to Europe.

Europe has a vibrant early-stage community of startups across the 4 Ds: Drugs, Devices, Diagnostics and Digital Health. Within the broader life sciences sector, including CROs and other service providers, research institutions and investment firms, our data tracks over 5,000 such companies around Europe that we have broken down below. In addition, the role startups play in moving the industry forward is evidenced by the fact that 2/3 of the assets in therapeutics are still in development.

 

Below is a list of all of the locations where LSN has been holding our Fundraising Bootcamps over the past 18 months, where we have recruited, trained and held one-on-one coaching sessions at some of the main tech hubs in Europe.  All told, LSN has reached almost 600 companies in the last year through our on-site Bootcamps, helping these companies expand outside their regions and enter LSN’s global ecosystem.

 

Registration Now Open for Inaugural 4D Meets AI Conference

5 Mar

By Chris Kennedy, Vice President Strategic Initiatives, 4D Meets AI, LSN

chris headshot

Artificial Intelligence (AI) is a transformative force in healthcare industry. From hospital care to clinical research, drug development and insurance, AI applications are revolutionizing how the health sector works to reduce spending and improve patient outcomes.

Seeing such tremendous potential of AI in the life science and healthcare domains, LSN created the 4D Meets AI Conference. Registration is now open for the September 22, 2020 event to be held at the Copley Marriott, Boston. www.4dmeetsai.com

Stemming from our long-standing RESI conference series, 4D Meets AI will continue doing what LSN does best – connecting early-stage companies that develop cutting-edge AI technology in drugs, devices, diagnostics and digital health, the ‘4Ds,’ with the right investors and decision-makers in the industry.

The 4D Meets AI conference is organized around those early stage companies in the drugs, devices, diagnostics and digital health verticals that are advancing the state of the art by using new tools and methodologies that AI brings to this dynamic sector. The conference is first and foremost a partnering conference for both buyers and sellers of early stage companies leveraging the power of AI technology.

Hot Investor Mandate : Europe VC Invests in New Healthtech Platforms

5 Mar

A venture capital firm based in Switzerland has raised 4 funds to make equity investments into internet and health tech companies at seed and early stages. The typical investment size ranges from €0.2 million to € 5 million. The firm plans to make 15-20 investments in the next 3 years and it will invest in companies based in Europe with a focus on Switzerland and Germany.

The firm is currently looking for new opportunities in the area of platform technologies, diagnostics, digital health, medtech etc.. The firm focuses on companies developing biotech platforms, research tools and digital health startups. The firm will not invest in pure drug development companies. In the past, the firm was active in companies developing proteomics platform technology, 3D micro tissues technology, diagnostic services, vaccines, antibody development platforms and a technology platform to develop virus envelopes.

The firm typically seeks to invest in private companies with convincing founders or managers. The firm will consider pre-revenue companies.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

Hot Investor Mandate : Preventative Health Firm Opens Seed Fund to Invest in Reducing Healthcare Costs

5 Mar

A major provider of preventative and diagnostic services in Europe has a $50M seed stage fund through which they invest mainly in Seed to Series A companies across all geographies. The firms are separate entities and as an institutional venture capital firm, financial return is an important factor. However, because of this affiliation, the seend fund is able to leverage corporate benefits to support the growing needs of their portfolio companies. The firm has invested in Europe and the USA. Initial sizes of investment can largely vary, from $250K to 3M and a portion of their fund is reserved for follow-on investment.

Traditionally, the fund has been most interested in healthcare IT and services companies that address important problems in the healthcare industry, including reducing healthcare costs and improving patient outcomes. However, the firm has been pushing beyond healthtech and pursuing investments in the fields of diagnostics, genomics, and medtech. The firm is not interested in biotech.

The fund is able to leverage their relationship with the parent company to provide hands-on support for their portfolio companies. The firm is open to both leading and co-investing and has done both. The firm does not have specific requirements for the company or management team as long as they have compelling technology.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.